Milestone Pharmaceuticals (MIST) Institutional Ownership $1.72 +0.02 (+0.88%) As of 03:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Milestone Pharmaceuticals (NASDAQ:MIST)CurrentInstitutional OwnershipPercentage86.18%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$6.86MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$7.37M Get MIST Insider Trade Alerts Want to know when executives and insiders are buying or selling Milestone Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MIST Institutional Buying and Selling by Quarter Milestone Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Raymond James Financial Inc.43,235$84K0.0%+30.1%0.081% 8/13/2025 Walleye Capital LLC15,109$29K0.0%-83.6%0.028% 8/12/2025 XTX Topco Ltd160,963$312K0.0%+209.5%0.301% 8/8/2025 Creative Planning23,410$45K0.0%+74.6%0.044% 8/7/2025 Simplify Asset Management Inc.990,000$1.92M0.1%+16.5%1.852% 7/22/2025 Valeo Financial Advisors LLC130,699$254K0.0%+553.5%0.244% 7/9/2025 Bay Rivers Group14,321$28K0.0%N/A0.027% 5/15/2025 Propel Bio Management LLC1,451,557$1.16M1.3%N/A2.715% 5/14/2025 Stonepine Capital Management LLC250,000$200K0.2%-50.0%0.468% 5/14/2025 Walleye Capital LLC91,920$74K0.0%N/A0.172% Get the Latest News and Ratings for MIST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Milestone Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/12/2025 Alta Fundamental Advisers LLC1,427,479$1.14M0.7%-46.3%2.670% 5/8/2025 XTX Topco Ltd52,004$42K0.0%+52.7%0.097% 2/19/2025 Toronto Dominion Bank750,000$1.77M0.0%N/A1.406% 2/17/2025 Stonepine Capital Management LLC500,000$1.18M1.0%-50.0%0.938% 2/17/2025 Toronto Dominion Bank750,000$1.77M0.0%N/A1.406% 2/17/2025 RTW Investments LP2,506,102$5.91M0.1%-23.0%4.699% 2/17/2025 Millennium Management LLC2,703,259$6.38M0.0%-2.7%5.069% 2/17/2025 Lion Point Capital LP1,025,806$2.42M12.7%-38.0%1.924% 2/17/2025 Cubist Systematic Strategies LLC30,938$73K0.0%N/A0.058% 2/14/2025 Boxer Capital Management LLC309,007$729K0.1%N/A0.579% 2/14/2025 Nantahala Capital Management LLC1,445,264$3.41M0.1%-17.4%2.710% 2/14/2025 Northern Trust Corp58,108$137K0.0%+112.6%0.109% 2/14/2025 Two Sigma Securities LLC16,957$40K0.0%-26.7%0.032% 2/13/2025 XTX Topco Ltd34,054$80K0.0%N/A0.064% 2/13/2025 Envestnet Asset Management Inc.63,742$150K0.0%-9.7%0.120% 2/12/2025 National Bank of Canada FI18,700$44K0.0%+163.4%0.035% 2/11/2025 Virtu Financial LLC71,955$170K0.0%N/A0.135% 2/6/2025 Jones Financial Companies Lllp11,000$26K0.0%+1,000.0%0.021% 1/24/2025 Clear Creek Financial Management LLC10,500$25K0.0%-46.2%0.020% 11/25/2024PVG Asset Management Corp30,345$46K0.2%N/A0.057% 11/14/2024 Stonepine Capital Management LLC999,790$1.52M1.0%-19.3%1.877% 11/5/2024 BML Capital Management LLC1,136,091$1.73M1.0%+3.0%2.133% 11/1/2024 Atria Investments Inc40,421$61K0.0%+44.4%0.076% 10/10/2024 Valeo Financial Advisors LLC20,000$30K0.0%+100.0%0.038% 8/21/2024 Stonepine Capital Management LLC1,239,199$1.64M1.5%-15.3%2.327% 8/15/2024 Lion Point Capital LP2,340,207$3.09M5.6%+1.7%4.394% 8/15/2024 Millennium Management LLC2,749,930$3.66M0.0%-3.7%5.163% 5/1/2024 BNP Paribas Financial Markets16,900$30K0.0%+177.0%0.032% 4/26/2024 Clear Creek Financial Management LLC25,000$45K0.0%-21.3%0.047% 4/23/2024 BML Capital Management LLC606,145$1.09M0.7%+37.0%1.140% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo1/30/2024 BML Capital Management LLC442,352$739K0.6%+62.3%1.321% 9/21/2023 Barclays PLC800,776$2.28M0.0%-5.4%2.399% 8/21/2023 Affinity Asset Advisors LLC300,068$855K0.3%+50.5%0.899% 8/11/2023 Beta Wealth Group Inc.14,127$40K0.0%N/A0.042% 8/3/2023 Barclays PLC800,776$2.28M0.0%-5.4%2.400% 7/27/2023 Virtu Financial LLC11,743$33K0.0%N/A0.035% 7/24/2023 BML Capital Management LLC272,500$777K0.7%+23.9%0.817% 7/17/2023 Clear Creek Financial Management LLC31,929$91K0.0%-11.1%0.096% 7/14/2023 Valeo Financial Advisors LLC118,699$338K0.0%+4.4%0.356% 5/16/2023 Alta Fundamental Advisers LLC897,961$3.54M1.5%+58.8%2.698% 5/15/2023 Affinity Asset Advisors LLC199,382$786K0.3%+99.4%0.599% 5/15/2023 RTW Investments LP3,256,102$12.83M0.3%-24.5%9.782% 5/4/2023 Barclays PLC846,828$3.34M0.0%+32.0%2.544% 4/20/2023 Clear Creek Financial Management LLC35,929$142K0.0%N/A0.108% 4/14/2023 BML Capital Management LLC220,000$867K0.7%+22.2%0.661% 2/15/2023 Braidwell LP1,164,849$4.61M0.2%N/A3.397% 2/14/2023 VR Adviser LLC2,208,812$8.75M1.4%-8.9%6.442% 2/14/2023 Pura Vida Investments LLC371,788$1.47M0.1%-37.7%1.084% 2/13/2023 BML Capital Management LLC180,000$713K0.7%N/A0.525% 2/13/2023 Beta Wealth Group Inc.14,127$56K0.0%N/A0.041% 2/9/2023 Valeo Financial Advisors LLC113,699$450K0.0%+50.6%0.332% 2/1/2023 Bank of Montreal Can152,636$611K0.0%+217.3%0.445% 11/15/2022 Pura Vida Investments LLC596,531$5.48M0.3%-39.6%1.740% 11/15/2022Boxer Capital LLC698,861$6.42M0.4%-68.8%2.038% 11/14/2022 LMR Partners LLP38,495$354K0.0%+228.1%0.128% 11/14/2022 VR Adviser LLC2,425,737$22.29M3.3%N/A8.083% 11/3/2022 Barclays PLC540,582$4.97M0.0%+155.3%1.801% 10/31/2022 Valeo Financial Advisors LLC75,500$694K0.0%N/A0.252% 10/13/2022 National Bank of Canada FI2,880$26K0.0%-80.6%0.010% 8/15/2022 Acuta Capital Partners LLC457,200$2.81M1.6%+20.3%1.528% 2/14/2022Boxer Capital LLC2,238,861$14.67M0.6%-13.0%7.501% 2/14/2022 Eversept Partners LP147,165$964K0.1%+29.6%0.493% 2/10/2022 Bleichroeder LP250,000$1.64M0.3%N/A0.838% 2/10/2022 Acadian Asset Management LLC12,381$79K0.0%+63.0%0.041% 1/24/2022 National Bank of Canada FI14,742$96K0.0%N/A0.049% 11/16/2021 Millennium Management LLC695,241$3.97M0.0%-3.3%2.329% 11/15/2021 Pura Vida Investments LLC850,312$4.86M0.1%+21.0%2.849% 11/15/2021 Eversept Partners LP113,597$649K0.0%N/A0.381% 11/9/2021 Barclays PLC200,688$1.15M0.0%-1.6%0.672% 8/18/2021 Ikarian Capital LLC1,980,400$10.89M0.9%+7.8%6.635% 8/17/2021 Boothbay Fund Management LLC224,758$1.24M0.0%+7.9%0.753% 8/16/2021Morgan Stanley885,199$4.87M0.0%+4.0%2.966% 8/13/2021 Renaissance Technologies LLC107,554$592K0.0%-50.3%0.360% 8/12/2021 Dimensional Fund Advisors LP47,200$260K0.0%+23.2%0.158% 8/11/2021 Susquehanna Fundamental Investments LLC51,502$283K0.0%-15.1%0.173% 5/18/2021Morgan Stanley851,042$4.93M0.0%-13.0%2.851% 5/17/2021 Goldman Sachs Group Inc.12,004$70K0.0%-46.0%0.040% (Data available from 1/1/2016 forward) MIST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MIST shares? During the previous two years, 30 institutional investors and hedge funds held shares of Milestone Pharmaceuticals. The most heavily invested institutionals were Millennium Management LLC ($6.38M), RTW Investments LP ($5.91M), Nantahala Capital Management LLC ($3.41M), Lion Point Capital LP ($2.42M), Barclays PLC ($2.28M), Simplify Asset Management Inc. ($1.92M), and Toronto Dominion Bank ($1.77M).Learn more on Milestone Pharmaceuticals' institutional investors. What percentage of Milestone Pharmaceuticals' stock is owned by institutional investors? 86.18% of Milestone Pharmaceuticals' stock is owned by institutional investors. Learn more on MIST's institutional investor holdings. Which institutional investors have been buying Milestone Pharmaceuticals' stock? Of the 21 institutional investors that purchased Milestone Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($1.50M), Propel Bio Management LLC ($1.45M), BML Capital Management LLC ($366.84K), Boxer Capital Management LLC ($309.01K), XTX Topco Ltd ($160.96K), Simplify Asset Management Inc. ($140K), and Valeo Financial Advisors LLC ($120.70K). How much institutional buying is happening at Milestone Pharmaceuticals? Institutional investors have bought a total of 4,039,703 shares in the last 24 months. This purchase volume represents approximately $6.86M in transactions. Which of Milestone Pharmaceuticals' major shareholders have been selling company stock? Of the 10 institutional investors that sold Milestone Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Alta Fundamental Advisers LLC ($1.23M), Stonepine Capital Management LLC ($1.21M), RTW Investments LP ($750K), Lion Point Capital LP ($628.35K), Nantahala Capital Management LLC ($304.74K), Walleye Capital LLC ($76.81K), and Millennium Management LLC ($75.27K). How much institutional selling is happening at Milestone Pharmaceuticals? Institutional investors have sold a total of 4,300,591 shares in the last 24 months. This volume of shares sold represents approximately $7.37M in transactions. Related Companies ABEO Major Shareholders OLMA Major Shareholders ALDX Major Shareholders AMRN Major Shareholders BNTC Major Shareholders RCKT Major Shareholders INBX Major Shareholders NGNE Major Shareholders CADL Major Shareholders LRMR Major Shareholders This page (NASDAQ:MIST) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersBiotech Alert: With news on MPox, RSV, and more, this tiny firm could disrupt a $3B marketA small biotech is stepping into the spotlight with a first-in-class antiviral platform—and it could be one of...Smallcaps Daily | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access